Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRQIH.L Regulatory News (RQIH)

  • There is currently no data for RQIH

Statement re Press Comment

22 Sep 2023 07:00

RNS Number : 2899N
R&Q Insurance Holdings Ltd
22 September 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

22 September 2023

 

R&Q Insurance Holdings Ltd

 

Statement regarding the recent press comment in relation to the sale of Accredited

 

The Board of R&Q Insurance Holdings Ltd ("R&Q", the "Company") notes the press commentary regarding a potential sale of the Company's Program Management business, Accredited.

 

As previously announced, the Board has been undertaking a review of the strategic options for the Group, which has included the legal separation of Accredited and R&Q Legacy. The Board confirms that it is in an advanced stage of discussions with Onex Corporation ("Onex") regarding a potential sale of Accredited.

 

If and when appropriate, a further announcement will be made.

 

Ends

 

 

 Enquiries to:

 

R&Q Insurance Holdings Ltd Tel: +44(0)20 7780 5850

William Spiegel

Tom Solomon

 

Fenchurch Advisory Partners LLP (Financial Adviser) Tel: +44 (0)20 7382 2222

Kunal Gandhi

John Sipp

Brendan Perkins

Richard Locke

Tihomir Kerkenezov

 

Barclays Bank PLC (Financial Adviser and Joint Broker) Tel: +44 (0)20 7632 2322

Gary Antenberg

Andrew Tusa

Michael Hart

 

Numis Securities Limited (Nominated Adviser and Joint Broker) Tel : +44 (0)20 7260 1000

Charles Farquhar

Giles Rolls

 

FTI Consulting Tel: +44 (0)20 3727 1051

Tom Blackwell

 

Tel: 020 3727 1051

 

 

Notes to Editors:

 

About R&Q 

 

R&Q is a non-life global specialty insurance company operating two highly complementary businesses: Program Management and Legacy Insurance. Both of these businesses are leaders in markets with high barriers to entry and significant growth opportunities. Legacy Insurance generates profits and capital extractions from expert management of legacy non-life insurance portfolios. Program Management generates commission income from its licensed (and rated) carriers in the US, EU and the UK, writing niche and profitable program business, largely on behalf of highly rated reinsurers.

Legal Entity Identifier (LEI): 2138006K1U38QCGLFC94

 

Website: www.rqih.com

 

Important Notices

 

This announcement is for information purposes only.

 

This announcement is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote in any jurisdiction.

 

The release, publication or distribution of this announcement in jurisdictions outside the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions. Any failure to comply with such restrictions may constitute a violation of the securities law of any such jurisdiction.

 

Fenchurch Advisory Partners LLP, which is authorised and regulated by the Financial Conduct Authority (the "FCA") in the United Kingdom, is acting exclusively for R&Q and for no one else in connection with the subject matter of this announcement and will not be responsible to anyone other than R&Q for providing the protections afforded to clients of Fenchurch Advisory Partners LLP nor for providing advice in connection with the subject matter of this announcement.

 

Barclays Bank PLC ("Barclays") is authorised by the Prudential Regulation Authority (the "PRA") and regulated in the United Kingdom by the PRA and the FCA. Barclays is acting exclusively for the Company and no one else in connection with the content of this announcement or any matters described in this announcement. Barclays will not regard any other person as its client in relation to the content of this announcement or any matters described in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice to any other person in relation to any matter referred to herein.

 

Numis Securities Limited ("Numis"), which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively for R&Q and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters in this announcement and will not be responsible to anyone other than R&Q for providing the protections afforded to clients of Numis, nor for providing advice in relation to any matter referred to herein.

 

Certain statements contained in this announcement constitute "forward-looking statements" with respect to the financial condition, results of operations and businesses and plans of the Company and its subsidiaries (the "Group"). Words such as "believes", "anticipates", "estimates", "expects", "intends", "plans", "aims", "potential", "will", "would", "could", "considered", "likely", "estimate" and variations of these words and similar future or conditional expressions, are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. These statements and forecasts involve risk and uncertainty because they relate to events and depend upon future circumstances that have not occurred. There is a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements and forecasts. As a result, the Group's actual financial condition, results of operations and business and plans may differ materially from the plans, goals and expectations expressed or implied by these forward-looking statements. No representation or warranty is made as to the achievement or reasonableness of, and no reliance should be placed on, such forward-looking statements. The forward-looking statements contained in this announcement speak only as of the date of this announcement. The Company, its directors, Barclays, Fenchurch Advisory Partners LLP, Numis, their respective affiliates and any person acting on its or their behalf each expressly disclaim any obligation or undertaking to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, unless required to do so by applicable law or regulation of the London Stock Exchange.

 

Unless explicitly labelled as such, no statement in this announcement is intended to be a profit forecast or profit estimate for any period, and no statement in this announcement should be interpreted to mean that earnings, earnings per share or income, cash flow from operations or free cash flow for the Company for the current or future financial years would necessarily match or exceed the historical published earnings, earnings per share or income, cash flow from operations or free cash flow for the Company.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SPCLFLLLXKLBBBV
Date   Source Headline
8th Oct 20197:39 amRNSCompletion of acquisition
2nd Oct 20192:12 pmRNSResult of General Meeting
2nd Oct 20197:00 amRNSR&Q appoints Chief Restructuring Officer
25th Sep 20197:00 amRNSA.M. Best rating
9th Sep 20199:59 amRNSNotice of General Meeting and Return of Capital
6th Sep 20197:01 amRNSRetirement of Director
6th Sep 20197:00 amRNSInterim Results
22nd Aug 20197:00 amRNSLegacy agreement
21st Aug 20197:00 amRNSProgram underwriting partnerships
8th Aug 20197:00 amRNSR&Q provides legacy reinsurance for captive
12th Jul 20197:00 amRNSDirectors' Shareholding/Total Voting Rights
3rd Jul 20197:00 amRNSLoss Portfolio Transfer
1st Jul 20197:00 amRNSAcquisition
1st Jul 20197:00 amRNSTransaction with Phoenix Asset Management Partners
19th Jun 20194:49 pmRNSAnnual Report & Accounts
19th Jun 20197:00 amRNSDirectorate Change
13th Jun 20197:00 amRNSResult of Annual General Meeting
21st May 20197:50 amRNSDirectors' Shareholding/Total Voting Rights
20th May 20197:00 amRNSNotice of AGM and Proposed Return of Capital
8th May 20195:30 pmRNSEarthport
7th May 201910:58 amRNSDirectors' Shareholding/Total Voting Rights
7th May 20197:00 amRNSBoard Appointment
3rd May 20197:00 amRNSCompletion of Acquisition
30th Apr 20197:00 amRNSPDMR Shareholding/Total Voting Rights
29th Apr 20197:00 amRNSFinal results
23rd Apr 201912:24 pmRNSRegulatory approval for acquisition
1st Apr 20197:00 amRNSAcquisition
25th Mar 20197:00 amRNSListing of Senior Unsecured Floating Rate Notes
21st Mar 20197:00 amRNSProgram underwriting partnership
20th Mar 20198:00 amRNSAccredited A.M. Best Group rating increase
15th Mar 201911:05 amRNSNotification of major interest in shares
6th Mar 20192:30 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
6th Mar 20192:30 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
6th Mar 20192:30 pmRNSPDMR Share Dealings
5th Mar 201912:05 pmRNSResult of General Meeting and Open Offer
4th Mar 20197:00 amRNSAcquisition
25th Feb 20197:00 amRNSProgram underwriting partnership
14th Feb 20197:00 amRNSAM Best affirms ratings
8th Feb 20199:00 amRNSPosting of Circular
7th Feb 20197:00 amRNSPlacing and open offer
10th Jan 20197:00 amRNSR&Q completes on two further transactions
8th Jan 201912:13 pmRNSCompletion of acquisition
7th Jan 20197:00 amRNSProgram underwriting partnership
4th Jan 201910:12 amRNSDirectors' Shareholding
3rd Jan 20197:00 amRNSProgram underwriting partnership
11th Dec 201811:53 amRNSUpdate on Acquisition
28th Nov 20187:00 amRNSR&Q completes two transactions
30th Oct 201812:15 pmRNSResult of General Meeting
30th Oct 20188:00 amRNSFacultative reinsurance certificate to US carrier
8th Oct 20187:00 amRNSPDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.